m-Trifluoromethyl-diphenyl Diselenide Regulates Prefrontal Cortical MOR and KOR Protein Levels and Abolishes the Phenotype Induced by Repeated Forced Swim Stress in Mice
Tóm tắt
The present study aimed to investigate the m-trifluoromethyl-diphenyl diselenide [(m-CF3-PhSe)2] effects on prefrontal cortical MOR and KOR protein levels and phenotype induced by repeated forced swim stress (FSS) in mice. Adult Swiss mice were subjected to repeated FSS sessions, and after that, they performed the spontaneous locomotor/exploratory activity, tail suspension, and splash tests. (m-CF3-PhSe)2 (0.1 to 5 mg/kg) was administered to mice 30 min before the first FSS session and 30 min before the subsequent repeated FSS. (m-CF3-PhSe)2 abolished the phenotype induced by repeated FSS in mice. In addition, a single FSS session increased μ but reduced δ-opioid receptor contents, without changing the κ content. Mice subjected to repeated FSS had an increase in the μ content when compared to those of naïve group or subjected to single FSS. Repeated FSS induced an increase of δ-opioid receptor content compared to those mice subjected to single FSS. However, the δ-opioid receptor contents were lower than those found in the naïve group. The mice subjected to repeated FSS showed an increase in the κ-opioid receptor content when compared to that of the naïve mice. (m-CF3-PhSe)2 regulated the protein contents of μ and κ receptors in mice subjected to repeated FSS. These findings demonstrate that (m-CF3-PhSe)2 was effective to abolish the phenotype induced by FSS, which was accompanied by changes in the contents of cortical μ- and κ-opioid receptors.
Tài liệu tham khảo
Atwoli L, Stein DJ, Koenen KC, McLaughlin KA (2015) Epidemiology of posttraumatic stress disorder: prevalence, correlates and consequences. Curr Opin Psychiatry 28(4):307–311. https://doi.org/10.1097/YCO.0000000000000167
Koolhaas JM, de Boer SF, Coppens CM, Buwalda B (2010) Neuroendocrinology of coping styles: towards understanding the biology of individual variation. Front Neuroendocrinol 31(3):307–321. https://doi.org/10.1016/j.yfrne.2010.04.001
Binder EB, Nemeroff CB (2010) The CRF system, stress, depression and anxiety—insights from human genetic studies. Nature Publishing Group,
WHO (2012) Depression: a global crisis. Available at: http://www.who.int/mental_health/management/depression/wfmh_paper_depression_wmhd_2012.pdf
Bali A, Randhawa PK, Jaggi AS (2015) Stress and opioids: role of opioids in modulating stress-related behavior and effect of stress on morphine conditioned place preference. Neurosci Biobehav Rev 51:138–150. https://doi.org/10.1016/j.neubiorev.2014.12.018
Nummenmaa L, Tuominen L (2017) Opioid system and human emotions. Br J Pharmacol. https://doi.org/10.1111/bph.13812
Zalsman G, Molcho A, Huang Y, Dwork A, Li S, Mann JJ (2005) Postmortem mu-opioid receptor binding in suicide victims and controls. J Neural Transm (Vienna) 112(7):949–954. https://doi.org/10.1007/s00702-004-0239-3
Nogueira CW, Rocha JB (2011) Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds. Arch Toxicol 85(11):1313–1359. https://doi.org/10.1007/s00204-011-0720-3
Ibrahim M, Muhammad N, Naeem M, Deobald AM, Kamdem JP, Rocha JB (2015) In vitro evaluation of glutathione peroxidase (GPx)-like activity and antioxidant properties of an organoselenium compound. Toxicol in Vitro 29(5):947–952. https://doi.org/10.1016/j.tiv.2015.03.017
Oliveira CE, Marcondes Sari MH, Zborowski VA, Prado VC, Nogueira CW, Zeni G (2016) Pain-depression dyad induced by reserpine is relieved by p,p′-methoxyl-diphenyl diselenide in rats. Eur J Pharmacol 791:794–802. https://doi.org/10.1016/j.ejphar.2016.10.021
Quines CB, Rosa SG, Velasquez D, Da Rocha JT, Neto JS, Nogueira CW (2016) Diphenyl diselenide elicits antidepressant-like activity in rats exposed to monosodium glutamate: a contribution of serotonin uptake and Na(+), K(+)-ATPase activity. Behav Brain Res 301:161–167. https://doi.org/10.1016/j.bbr.2015.12.038
Bruning CA, Martini F, Soares SM, Savegnago L, Sampaio TB, Nogueira CW (2015) Depressive-like behavior induced by tumor necrosis factor-alpha is attenuated by m-trifluoromethyl-diphenyl diselenide in mice. J Psychiatr Res 66-67:75–83. https://doi.org/10.1016/j.jpsychires.2015.04.019
Savegnago L, Jesse CR, Nogueira CW (2009) Structural modifications into diphenyl diselenide molecule do not cause toxicity in mice. Environ Toxicol Pharmacol 27(2):271–276. https://doi.org/10.1016/j.etap.2008.11.007
Bruning CA, Martini F, Soares SM, Sampaio TB, Gai BM, Duarte MM, Nogueira CW (2015) m-Trifluoromethyl-diphenyl diselenide, a multi-target selenium compound, prevented mechanical allodynia and depressive-like behavior in a mouse comorbid pain and depression model. Prog Neuro-Psychopharmacol Biol Psychiatry 63:35–46. https://doi.org/10.1016/j.pnpbp.2015.05.011
Bruning CA, Souza AC, Gai BM, Zeni G, Nogueira CW (2011) Antidepressant-like effect of m-trifluoromethyl-diphenyl diselenide in the mouse forced swimming test involves opioid and serotonergic systems. Eur J Pharmacol 658(2–3):145–149. https://doi.org/10.1016/j.ejphar.2011.02.039
Rosa SG, Pesarico AP, Tagliapietra CF, da Luz SCA, Nogueira CW (2017) Opioid system contribution to the antidepressant-like action of m-trifluoromethyl-diphenyl diselenide in mice: a compound devoid of tolerance and withdrawal syndrome. J Psychopharmacol 31:1250–1262. https://doi.org/10.1177/0269881117724353
Paulmier C (1986) Selenoorganic functional groups. In: Paulmier C (ed) Selenium reagents and intermediates in organic synthesis, 1st edn. Prgamon Press, Oxford, pp. 25–51
Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice—primary screening-test for antidepressants. Arch Int Pharmacod T 229(2):327–336
Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85(3):367–370
Isingrini E, Camus V, Le Guisquet AM, Pingaud M, Devers S, Belzung C (2010) Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in mice. PLoS One 5(4):e10404. https://doi.org/10.1371/journal.pone.0010404
York JM, Blevins NA, McNeil LK, Freund GG (2013) Mouse short- and long-term locomotor activity analyzed by video tracking software. J Vis Exp (76). doi:https://doi.org/10.3791/50252
Knoll AT, Carlezon WA Jr (2010) Dynorphin, stress, and depression. Brain Res 1314:56–73. https://doi.org/10.1016/j.brainres.2009.09.074
Rogoz Z, Kabzinski M, Sadaj W, Rachwalska P, Gadek-Michalska A (2012) Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test. Pharmacol Rep 64(6):1391–1399
Rosa SG, Pesarico AP, Nogueira CW (2018) m-Trifluoromethyl-diphenyl diselenide promotes resilience to social avoidance induced by social defeat stress in mice: contribution of opioid receptors and MAPKs. Prog Neuro-Psychopharmacol Biol Psychiatry 82:123–135. https://doi.org/10.1016/j.pnpbp.2017.11.021
Bodnar RJ (2017) Endogenous opiates and behavior: 2015. Peptides 88:126–188. https://doi.org/10.1016/j.peptides.2016.12.004
McEwen BS (2007) Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 87(3):873–904. https://doi.org/10.1152/physrev.00041.2006
Berrocoso E, Ikeda K, Sora I, Uhl GR, Sanchez-Blazquez P, Mico JA (2013) Active behaviours produced by antidepressants and opioids in the mouse tail suspension test. Int J Neuropsychopharmacol 16(1):151–162. https://doi.org/10.1017/S1461145711001842
Rojas-Corrales MO, Berrocoso E, Gibert-Rahola J, Mico JA (2002) Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats. Life Sci 72(2):143–152
Tejedor-Real P, Mico JA, Maldonado R, Roques BP, Gibert-Rahola J (1995) Implication of endogenous opioid system in the learned helplessness model of depression. Pharmacol Biochem Behav 52(1):145–152
Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F, Befort K, Gaveriaux-Ruff C et al (2000) Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25(2):195–200. https://doi.org/10.1038/76061
Yoo JH, Lee SY, Loh HH, Ho IK, Jang CG (2004) Altered emotional behaviors and the expression of 5-HT1A and M1 muscarinic receptors in micro-opioid receptor knockout mice. Synapse 54(2):72–82. https://doi.org/10.1002/syn.20067
Komatsu H, Ohara A, Sasaki K, Abe H, Hattori H, Hall FS, Uhl GR, Sora I (2011) Decreased response to social defeat stress in mu-opioid-receptor knockout mice. Pharmacol Biochem Behav 99(4):676–682. https://doi.org/10.1016/j.pbb.2011.06.008
Nikulina EM, Hammer RP Jr, Miczek KA, Kream RM (1999) Social defeat stress increases expression of mu-opioid receptor mRNA in rat ventral tegmental area. Neuroreport 10(14):3015–3019
Yamamoto M, Komori T, Matsumoto T, Zhang K, Miyahara S, Shizuya K, Okazaki Y (2003) Effects of single and repeated prolonged stress on mu-opioid receptor mRNA expression in rat gross hypothalamic and midbrain homogenates. Brain Res 980(2):191–196
Lutz PE, Kieffer BL (2013) Opioid receptors: distinct roles in mood disorders. Trends Neurosci 36(3):195–206. https://doi.org/10.1016/j.tins.2012.11.002
Van Loon GR, Pierzchala K, Houdi AA, Kvetnansky R, Zeman P (1990) Tolerance and cross-tolerance to stress-induced increases in plasma met-enkephalin in rats with adaptively increased resting secretion. Endocrinology 126(4):2196–2204. https://doi.org/10.1210/endo-126-4-2196
Bruchas MR, Xu M, Chavkin C (2008) Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2. Neuroreport 19(14):1417–1422. https://doi.org/10.1097/WNR.0b013e32830dd655
McLaughlin JP, Li S, Valdez J, Chavkin TA, Chavkin C (2006) Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system. Neuropsychopharmacology 31(6):1241–1248. https://doi.org/10.1038/sj.npp.1300872
McLaughlin JP, Marton-Popovici M, Chavkin C (2003) Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23(13):5674–5683
Wang Q, Long Y, Hang A, Zan GY, Shu XH, Wang YJ, Liu JG (2016) The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel kappa agonist and mu partial agonist, in mice. Psychopharmacology 233(12):2411–2418. https://doi.org/10.1007/s00213-016-4292-z
Richards EM, Mathews DC, Luckenbaugh DA, Ionescu DF, Machado-Vieira R, Niciu MJ, Duncan WC, Nolan NM et al (2016) A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression. Psychopharmacology 233(6):1119–1130. https://doi.org/10.1007/s00213-015-4195-4
Saitoh A, Sugiyama A, Nemoto T, Fujii H, Wada K, Oka J, Nagase H, Yamada M (2011) The novel delta opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions. Behav Brain Res 223(2):271–279. https://doi.org/10.1016/j.bbr.2011.04.041
Yamada K, Nabeshima T (1995) Stress-induced behavioral responses and multiple opioid systems in the brain. Behav Brain Res 67(2):133–145
Haj-Mirzaian A, Kordjazy N, Ostadhadi S, Amiri S, Dehpour A (2016) Fluoxetine reverses the behavioral despair induced by neurogenic stress in mice: role of N-methyl-d-aspartate and opioid receptors. Can J Physiol Pharmacol 94(6):599–612. https://doi.org/10.1139/cjpp-2015-0429
Berrocoso E, Mico JA (2009) Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression. Int J Neuropsychopharmacol 12(8):1033–1044. https://doi.org/10.1017/S1461145709000236